Product Overview
ActHIB® is a Haemophilus influenzae type b (Hib) conjugate vaccine indicated for the active immunization of infants and children 2 months through 5 years of age. This vaccine helps prevent invasive diseases caused by Hib, such as meningitis, pneumonia, and epiglottitis.
Product Features
- ActHIB is a vaccine indicated for the prevention of invasive disease caused by Haemophilus influenzae type b
- ActHIB vaccine is approved for use as a four dose series in infants and children 2 months through 5 years of age
Product Specifications
| Catalog Number/SKU | MF-49281054503 |
| Application | Haemophilus Influenzae Type b Vaccine (Hib) |
| Container Type | Single-Dose Vial |
| Dosage Form | Injection |
| Generic Drug Code | 99298 |
| Generic Drug Name | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate), Preservative Free |
| NDC Number | 49281054503 |
| Storage | Requires Refrigeration |
| Strength | 10 mcg / 0.5 mL |
| Type | Intramuscular |
| UNSPSC Code | 51201627 |
| User | Indicated for People 2 Months to 5 Years of Age |
| Volume | 0.5 ml |
